WEDNESDAY DEEP DIVE ANALYSIS
ADPT (Adaptive Biotechnologies) - Immune Medicine Platform M&A Target
Exclusive for Paid Subscribers | December 17, 2025
📋 EXECUTIVE SUMMARY
Target Company: ADPT - Adaptive Biotechnologies Corp.
Current Price: $16.12
Market Cap: $2.43B
M&A Probability Score: 74/100 (HIGH PROBABILITY)
Estimated Timeline: 3-9 months
Potential Upside: 55-110% ($25-$34 acquisition range)
Risk Level: ⚠️⚠️⚠️ (3/5 - MODERATE-HIGH)
